Wordt geladen...
Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
BACKGROUND: Indacaterol is a novel, inhaled, once-daily, ultra-long-acting β(2)-agonist for the treatment of chronic obstructive pulmonary disease (COPD). This randomized, double-blind study compared the bronchodilator efficacy of indacaterol with that of placebo and tiotropium in patients with mode...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2964613/ https://ncbi.nlm.nih.gov/pubmed/20920365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-11-135 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|